A Photosensitizer-Loaded Polydopamine Nanomedicine Agent for Synergistic Photodynamic and Photothermal Therapy.
nanomedicine
photodynamic therapy
photosensitizer
photothermal therapy
synergistic therapy
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
04 Aug 2023
04 Aug 2023
Historique:
received:
29
06
2023
revised:
20
07
2023
accepted:
02
08
2023
medline:
14
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Photodynamic therapy (PDT) and photothermal therapy (PTT) have emerged as promising non-invasive approaches to cancer treatment. However, the development of multifunctional nanomedicines is necessary to enhance these approaches' effectiveness and safety. In this study, we investigated a polydopamine-based nanoparticle (PDA-ZnPc
Identifiants
pubmed: 37570844
pii: molecules28155874
doi: 10.3390/molecules28155874
pmc: PMC10420639
pii:
doi:
Substances chimiques
Photosensitizing Agents
0
polydopamine
0
zinc(II) phthalocyanine trisulfonic acid
61569-02-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Natural Science Foundation Cultivation Project
ID : PYT2004
Organisme : Natural Science Foundation of Fujian Province
ID : 2022J011173
Organisme : Guiding Project of Sanming Science and Technology Plan
ID : 2020-S-9
Organisme : the Start-up Foundation for Advanced Talents in Sanming University
ID : 18YG04
Références
Colloids Surf B Biointerfaces. 2021 Dec;208:112125
pubmed: 34601352
ACS Appl Mater Interfaces. 2021 Jun 23;13(24):27749-27773
pubmed: 34110790
Chem Commun (Camb). 2021 Aug 5;57(63):7731-7742
pubmed: 34286722
Front Chem. 2019 Jul 12;7:471
pubmed: 31355178
Adv Mater. 2022 Jun;34(24):e2109210
pubmed: 35142395
Adv Healthc Mater. 2019 Jul;8(13):e1900132
pubmed: 31067008
Appl Microbiol Biotechnol. 2017 Jun;101(11):4691-4700
pubmed: 28251266
Acta Biomater. 2022 Jun;145:135-145
pubmed: 35381398
J Pers Med. 2021 Feb 14;11(2):
pubmed: 33672813
J Appl Biomed. 2022 Oct;20(3):98-105
pubmed: 36218130
Theranostics. 2022 Jan 1;12(1):434-458
pubmed: 34987658
ChemMedChem. 2022 Jul 5;17(13):e202200185
pubmed: 35507015
World J Stem Cells. 2020 Jul 26;12(7):562-584
pubmed: 32843914
Int J Mol Sci. 2022 Feb 01;23(3):
pubmed: 35163607
Bioact Mater. 2020 Dec 26;6(7):1973-1987
pubmed: 33426371
Int J Biochem Cell Biol. 2019 Sep;114:105575
pubmed: 31362060
Dalton Trans. 2022 Sep 13;51(35):13157-13175
pubmed: 36018269
Theranostics. 2020 Jun 25;10(17):7921-7924
pubmed: 32685029
J Control Release. 2020 Dec 10;328:251-262
pubmed: 32889053
Cancer Treat Rev. 2020 Jun;86:102019
pubmed: 32251926
Molecules. 2020 Jun 10;25(11):
pubmed: 32532030
Adv Mater. 2021 Oct;33(43):e2007778
pubmed: 34510563
Chem Rec. 2021 Apr;21(4):781-796
pubmed: 33634962
Theranostics. 2022 Sep 21;12(15):6762-6778
pubmed: 36185599
J Mater Chem B. 2022 Jun 1;10(21):4096-4104
pubmed: 35521641
Adv Sci (Weinh). 2021 Aug;8(16):e2100876
pubmed: 34085415
Biomed Pharmacother. 2018 Oct;106:1098-1107
pubmed: 30119176
Nanomedicine (Lond). 2022 Aug;17(18):1213-1216
pubmed: 36136592
J Mater Chem B. 2018 May 7;6(17):2620-2629
pubmed: 32254480
J Hematol Oncol. 2021 May 31;14(1):85
pubmed: 34059100
Nat Rev Clin Oncol. 2020 Nov;17(11):657-674
pubmed: 32699309
Biomater Sci. 2021 Nov 23;9(23):7811-7825
pubmed: 34755723
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Front Chem. 2021 Jun 10;9:691697
pubmed: 34178948
J Mater Chem B. 2018 Oct 14;6(38):6080-6088
pubmed: 32254818
CA Cancer J Clin. 2022 Sep;72(5):409-436
pubmed: 35736631
Int J Nanomedicine. 2020 Sep 15;15:6827-6838
pubmed: 32982235
Polymers (Basel). 2019 Mar 26;11(3):
pubmed: 30960552
Anticancer Agents Med Chem. 2021;21(2):149-161
pubmed: 32242788
Int J Mol Sci. 2019 Sep 05;20(18):
pubmed: 31491857